Oppenheimer Reiterates Outperform on WuXi PharmaTech and ShangPharma

by Emily Austin, Benzinga Staff Writer
June 27, 2011 7:48 AM | 11 seconds read |
Oppenheimer reiterated its Outperform rating on WuXi PharmaTech WX and ShangPharma SHP. On Friday, WuXi finished the day at $16.05, while ShangPharma close the day at $10.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: ReiterationAnalyst RatingsHealth CareLife Sciences Tools & ServicesOppenheimershangpharmaWuXi PharmaTech
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!